In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode CDC vaccine advisory group recommends RSV vaccines Association of culturable-virus detection and household transmission of SARS-CoV-2 (JID) Prevention of COVID-19 following intramuscular administration of Adintrevimab (OFID) Real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19 (CID) COVID-19 convalescent plasma outpatient therapy to prevent hospitalization (CID) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1018 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]